BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 32011108)

  • 1. Stimuli-activatable nanomedicines for chemodynamic therapy of cancer.
    Wang W; Jin Y; Xu Z; Liu X; Bajwa SZ; Khan WS; Yu H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1614. PubMed ID: 32011108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton and Fenton-like Reactions.
    Tang Z; Liu Y; He M; Bu W
    Angew Chem Int Ed Engl; 2019 Jan; 58(4):946-956. PubMed ID: 30048028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron-Based Theranostic Nanoplatform for Improving Chemodynamic Therapy of Cancer.
    Liu X; Jin Y; Liu T; Yang S; Zhou M; Wang W; Yu H
    ACS Biomater Sci Eng; 2020 Sep; 6(9):4834-4845. PubMed ID: 33455215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional nanomedicines-enabled chemodynamic-synergized multimodal tumor therapy via Fenton and Fenton-like reactions.
    Gao H; Cao Z; Liu H; Chen L; Bai Y; Wu Q; Yu X; Wei W; Wang M
    Theranostics; 2023; 13(6):1974-2014. PubMed ID: 37064867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of nanomedicine for photothermal-chemodynamic bimodal cancer therapy.
    Yao J; Zheng F; Yao C; Xu X; Akakuru OU; Chen T; Yang F; Wu A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1682. PubMed ID: 33185008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for enhancing cancer chemodynamic therapy performance.
    Jana D; Zhao Y
    Exploration (Beijing); 2022 Apr; 2(2):20210238. PubMed ID: 37323881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to engineer various nanocarrier-based hybrid catalysts for enhanced chemodynamic cancer therapy.
    Hao JN; Ge K; Chen G; Dai B; Li Y
    Chem Soc Rev; 2023 Nov; 52(22):7707-7736. PubMed ID: 37874584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of solid tumors by chemodynamic theranostics with H
    Wang N; Zeng Q; Zhang R; Xing D; Zhang T
    Theranostics; 2021; 11(5):2334-2348. PubMed ID: 33500728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocatalyst-Mediated Chemodynamic Tumor Therapy.
    Zhang L; Li CX; Wan SS; Zhang XZ
    Adv Healthc Mater; 2022 Jan; 11(2):e2101971. PubMed ID: 34751505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in multifunctional nanomaterials for photothermal-enhanced Fenton-based chemodynamic tumor therapy.
    Manivasagan P; Joe A; Han HW; Thambi T; Selvaraj M; Chidambaram K; Kim J; Jang ES
    Mater Today Bio; 2022 Jan; 13():100197. PubMed ID: 35036895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research Progress on Improving the Efficiency of CDT by Exacerbating Tumor Acidification.
    Chen W; Liu J; Zheng C; Bai Q; Gao Q; Zhang Y; Dong K; Lu T
    Int J Nanomedicine; 2022; 17():2611-2628. PubMed ID: 35712639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron oxide-EDTA nanoparticles for chelation-enhanced chemodynamic therapy and ion interference therapy.
    Chen C; Meng Q; Liu Z; Liu S; Tong W; An B; Ding B; Ma P; Lin J
    Biomater Sci; 2023 Jun; 11(13):4549-4556. PubMed ID: 37159049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing inorganic nanomaterials for chemodynamic cancer therapy.
    Mohammed DF; Madlool HA; Faris M; Shalan BH; Hasan HH; Azeez NF; Abbas FH
    Nanomedicine (Lond); 2022 Oct; 17(24):1891-1906. PubMed ID: 36647807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional carbon quantum dots as a theranostic nanomedicine for fluorescence imaging-guided glutathione depletion to improve chemodynamic therapy.
    Li J; Hu ZE; We YJ; Liu YH; Wang N; Yu XQ
    J Colloid Interface Sci; 2022 Jan; 606(Pt 2):1219-1228. PubMed ID: 34492460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Forward Vision for Chemodynamic Therapy: Issues and Opportunities.
    Zhao P; Li H; Bu W
    Angew Chem Int Ed Engl; 2023 Feb; 62(7):e202210415. PubMed ID: 36650984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-amplified activatable nanoprodrugs for enhanced chemodynamic/chemo combination therapy.
    He X; Liu M; Du M; Huang Y; Xu P; Xie C; Fan Q; Zhou W
    Nanotechnology; 2024 Feb; 35(17):. PubMed ID: 38262050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cu-MOF chemodynamic nanoplatform via modulating glutathione and H
    Tian H; Zhang M; Jin G; Jiang Y; Luan Y
    J Colloid Interface Sci; 2021 Apr; 587():358-366. PubMed ID: 33360905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.
    Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P
    Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in nanoscale metal-organic frameworks for cancer chemodynamic therapy.
    Ji M; Liu H; Gou J; Yin T; He H; Zhang Y; Tang X
    Nanoscale; 2023 May; 15(20):8948-8971. PubMed ID: 37129051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulating Intratumoral Fenton Chemistry for Enhanced Chemodynamic and Chemodynamic-Synergized Multimodal Therapy.
    Zhou Y; Fan S; Feng L; Huang X; Chen X
    Adv Mater; 2021 Dec; 33(48):e2104223. PubMed ID: 34580933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.